Stock Rating Report for LLY

Ticker: 

Stock Information

Ticker LLY
Company Name Eli Lilly and Co
Current Price $39.51
Previous Close $39.51
Industry Drug Manufacturers - Major
Sector HEALTHCARE
Long Stop Loss Members Only
Short Stop Loss Members Only
Expected Move Members Only
Optionable? Yes

StockProphet Ratings

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.

Sector Risks

Sign up for MarketProphet today to see our 30, 60, and 90 day risk assessment for this stock.


Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for LLY. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Eli Lilly and Co next week. Sign up today and start making money!

Demand Fundamentals

Demand Fundamental Value Score Rating
Qtr/Qtr Revenue Growth Members Only
Qtr/Qtr Earnings Growth Members Only
Year/Year Revenue Growth Members Only
Year/Year Earnings Growth Members Only
Multi-Year Revenue Growth Members Only
Multi-Year Earnings Growth Members Only
Relative PE Ranking Members Only
Return on Equity Members Only
Yield Members Only
Institutional Holding Members Only
Stock Price Members Only
Relative Fundamental Ranking Members Only
Total Score Members Only

Demand Technicals

Demand Technical Value Score Rating
Recommended Condition Members Only
Trading Zone Members Only
Average Trading Volume Members Only
Industry Bull/Bear Condition Members Only
Sector Bull/Bear Condition Members Only
Current Signal Start Date Members Only
Total Score Members Only

Company Profile

Eli Lilly and Company develops, manufactures, and sells pharmaceutical products worldwide. It offers neuroscience products to treat schizophrenia, manic episodes, and bipolar maintenance- depression and diabetic peripheral neuropathic pain- attention-deficit hyperactivity disorder in children, adolescents, and adults- bulimia nervosa and obsessive-compulsive disorders- and bipolar depression and treatment-resistant depression. The company's endocrinology products are used for diabetes- type 2 diabetes- osteoporosis in postmenopausal women- osteoporosis in postmenopausal women and men at high risk for fracture- and human growth hormone deficiency and pediatric growth conditions. It also provides oncology products to treat malignant pleural mesothelioma- pancreatic, metastatic breast, non-small cell lung, ovarian, and bladder cancers- and colorectal cancers, as well as offers cardiovascular products to treat erectile dysfunction and pulmonary arterial hypertension, for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome, as an adjunct to percutaneous coronary intervention, and to treat adults with severe sepsis at high risk of death. In addition, the company offers animal health products, such as cattle feed additives- antibiotics to treat respiratory and other diseases in cattle, swine, and poultry- leanness and performance enhancers for swine and cattle- protein supplements to improve milk productivity in dairy cows- anticoccidial agents- antibiotics to control enteric infections in calves and swine- parasiticides for use on cattle and premises- products to treat canine separation anxiety- and products that prevents flea infestations on dogs, as well as other pharmaceutical products to treat staphylococcal infections and bacterial infections. Eli Lilly distributes its products through independent wholesale distributors, as well as directly to pharmacies. The company was founded in 1876 and is based in Indianapolis, Indiana.


Latest News

Fri, 03 Feb 2012 23:23:21 GMTEli Lilly Freezes Salaries as Sales Slip After Best-Seller Faces Generics
Fri, 03 Feb 2012 19:53:58 GMTMerck Looks Like A Name To Own In Drugs
Fri, 03 Feb 2012 18:09:18 GMTBioLineRx: Strong Speculation Bio-Pharma, Strong Acquisition Target
Fri, 03 Feb 2012 17:56:29 GMTDr Reddy's fiscal 3Q profit jumps 87 percent
Fri, 03 Feb 2012 17:47:12 GMTThis Just In: Upgrades and Downgrades
Fri, 03 Feb 2012 15:54:19 GMTArmy Studies Workout Supplements After Deaths
Fri, 03 Feb 2012 15:15:23 GMTRevenues Skyrocket at Merged Alkermes
Fri, 03 Feb 2012 14:24:14 GMTAdocia Chief Seeks Partner Soon for Diabetic Foot-Sore Treatment
Fri, 03 Feb 2012 13:18:06 GMTS&P 500 Analyst Estimate Revisions for Feb. 3
Fri, 03 Feb 2012 12:01:15 GMTDIARY-U.S. MEETINGS/WEEK AHEAD
Fri, 03 Feb 2012 11:56:09 GMTDr Reddy's Labs Q3 net beats f'casts on U.S. sales
Fri, 03 Feb 2012 11:56:09 GMTDr Reddy's Labs Q3 net beats f'casts on U.S. sales
Fri, 03 Feb 2012 11:24:16 GMT[$$] Dr. Reddy's Profit Soars 88%
Fri, 03 Feb 2012 10:51:24 GMTUPDATE 1-India's Dr Reddy's Labs Q3 net beats f'casts on U.S. sales
Fri, 03 Feb 2012 08:04:21 GMTEquities End a Strong Month on a Mixed Note
Fri, 03 Feb 2012 05:01:00 GMTRick?s Imports Strippers as Indianapolis Readies for Super Bowl Revelers
Fri, 03 Feb 2012 02:15:17 GMTUltimate Market Recap: Cereal Companies Rise, Abercrombie Plummets 11%
Thu, 02 Feb 2012 22:29:55 GMTDrugmakers singing same song: 2012 will be tough
Thu, 02 Feb 2012 21:50:24 GMT[$$] Merck Swings to Profit on Fewer Charges, Sales Growth
Thu, 02 Feb 2012 17:53:00 GMTMerck Reports Mixed Q4, 2012 Outlook Below Forecasts
News provided by Yahoo! Finance